111 Price to Book Ratio 2018-2023 | YI
Historical price to book ratio values for 111 (YI) over the last 10 years. The current price to book ratio for 111 as of May 03, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| 111 Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-05-03 | 1.15 | inf | |
| 2023-09-30 | 2.60 | 0.00 | |
| 2023-06-30 | 2.46 | 0.00 | |
| 2023-03-31 | 2.65 | 0.00 | |
| 2022-12-31 | 3.02 | $-0.71 | -4.26 |
| 2022-09-30 | 2.68 | 0.00 | |
| 2022-06-30 | 2.06 | 0.00 | |
| 2022-03-31 | 2.66 | 0.00 | |
| 2021-12-31 | 3.50 | $-0.29 | -12.18 |
| 2021-09-30 | 6.17 | 0.00 | |
| 2021-06-30 | 9.09 | 0.00 | |
| 2021-03-31 | 13.80 | 0.00 | |
| 2020-12-31 | 6.95 | $0.75 | 9.23 |
| 2019-06-30 | 5.56 | $3.31 | 1.68 |
| 2019-03-31 | 6.49 | $3.58 | 1.81 |
| 2018-09-30 | 13.52 | $4.27 | 3.17 |
| 2020-09-30 | 6.20 | 0.00 | |
| 2020-06-30 | 6.35 | 0.00 | |
| 2020-03-31 | 6.61 | $1.15 | 5.76 |
| 2019-12-31 | 6.73 | $1.35 | 4.97 |
| 2019-09-30 | 4.87 | $1.60 | 3.04 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.096B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
| Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
| Axonics (AXNX) | United States | $3.432B | 0.00 |
| 10x Genomics (TXG) | United States | $3.275B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.196B | 0.00 |
| Azenta (AZTA) | United States | $2.979B | 242.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
| Enovis (ENOV) | United States | $2.812B | 20.84 |
| Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.224B | 98.63 |
| Schrodinger (SDGR) | United States | $1.712B | 0.00 |
| Omnicell (OMCL) | United States | $1.384B | 47.83 |
| Phreesia (PHR) | United States | $1.259B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
| Standard BioTools (LAB) | United States | $0.728B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
| Pulmonx (LUNG) | United States | $0.378B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| Outset Medical (OM) | United States | $0.162B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
| TruBridge (TBRG) | United States | $0.125B | 5.33 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |